US STOCK
TEVA Stock Analysis
US stocks · market data · technical indicators
Teva Pharmaceutical Industries Limited
TEVAUS stocksQuote delayed 15 min
10/27 上午08:00 updated
$39.95
+0.54+1.37%
Open
$39.22
High
$40.12
Low
$39.15
Volume
603.27萬
TEVA price history
+2.75%Open
38.88
Latest
39.95
High
41.50
Low
38.88
Average
40.17
Advertisement
Financial snapshot
TEVA - Teva Pharmaceutical Industries Limited
EPS
0.60USD
Forward EPS
3.09USD
P/E
66.58x
Forward P/E
12.94x
P/B
6.00x
ROE
9.69%
ROA
5.13%
Operating margin
4.03%
Profit margin
4.08%
Revenue growth
-0.80%
Earnings growth
--
Dividend yield
0.00%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.14B | $3.98B | $4.71B | $4.48B | $4.18B | — |
| Gross profit | $2.15B | $1.97B | $2.66B | $2.30B | $2.10B | — |
| Operating income | $149.00M | $759.00M | $1.27B | $1.07B | $899.00M | — |
| Net income | -$576.00M | $369.00M | $480.00M | $433.00M | $282.00M | — |
| Basic EPS | -0.49 | 0.32 | 0.42 | — | 0.25 | 0.19 |
| Diluted EPS | -0.49 | 0.31 | 0.41 | — | 0.24 | 0.18 |
Estimates vs actuals
Next earnings
2026-11-03
EPS estimate
0.73
Revenue estimate
$4.24B
Last surprise
-81.46%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-11-03 | 0.73 | Not reported | — |
| 2026-07-29 | 0.11 | 0.02 | -81.46% |
| 2026-04-29 | 0.46 | 0.53 | +16.23% |
| 2026-01-28 | 0.64 | 0.96 | +50.17% |
| 2025-11-05 | 0.67 | 0.78 | +15.74% |
| 2025-07-30 | 0.62 | 0.66 | +7.31% |
| 2025-05-07 | 0.46 | 0.52 | +12.20% |
| 2025-01-29 | 0.70 | 0.71 | +1.09% |
| 2024-11-06 | 0.66 | 0.69 | +4.38% |
| 2024-07-31 | 0.55 | 0.61 | +10.74% |
| 2024-05-08 | 0.51 | 0.48 | -6.69% |
| 2024-01-31 | 0.76 | 1.00 | +31.74% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| BlackRock Inc. | 2024-06-30 | $698.6M | 0.02% |
| STATE STREET CORP | 2026-06-30 | $641.6M | 0.02% |
| Bridgewater Associates, LP | 2026-06-30 | $44.9M | 0.18% |
| VANGUARD GROUP INC | 2025-12-31 | $28.5M | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $7.8M | 0.01% |
| CITADEL ADVISORS LLC | 2026-06-30 | $2.5M | 0.00% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$47.58
Target range
$42.00 – $55.00
Implied upside
19.11%
Strong buy
4
Buy
8
Hold
1
Sell
0
Strong sell
0
Advertisement